Colchicine for epidermolysis bullosa acquisita.
Epidermolysis bullosa acquisita (EBA) is a chronic subepidermal blistering disease that is difficult to treat. Recently one patient with severe EBA was described who responded dramatically to colchicine. Our purpose was to determine the efficacy of colchicine in the treatment of EBA. Four patients with severe EBA refractory to conventional therapy were treated with colchicine 0.6 to 1.5 mg a day for up to 4 years. In all four patients the lessening of skin fragility and the decrease in spontaneous blister formation were dramatic; few side effects were noted. Colchicine should be considered in the treatment of EBA.